Evidence map›Paper›PMID 39470840›Full record

ArticleMikrochimica acta2024

Tuning the properties of peptide imprinted nanoparticles for protein immunoprecipitation using magnetic streptavidin beads.

Ainhoa Elejaga-Jimeno, Alberto Gómez-Caballero, Gontzal García Del Caño, Nora Unceta, Miquel Saumell-Esnaola, Joan Sallés, M Aránzazu Goicolea, Ramón J Barrio

Abstract read
In one paragraph

Article in Mikrochimica acta, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ainhoa Elejaga-JimenoDepartment of Analytical Chemistry, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0001-8017-0517
Alberto Gómez-CaballeroDepartment of Analytical Chemistry, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz, Spain. a.gomez@ehu.eus.ORCID http://orcid.org/0000-0002-5753-9889
Gontzal García Del CañoDepartment of Neurosciences, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0002-7098-0986
Nora UncetaDepartment of Analytical Chemistry, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0002-6590-8816
Miquel Saumell-EsnaolaDepartment of Pharmacology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0003-0703-162X
Joan SallésDepartment of Pharmacology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0001-6727-2674
M Aránzazu GoicoleaDepartment of Analytical Chemistry, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0001-8276-2903
Ramón J BarrioDepartment of Analytical Chemistry, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0002-1685-6685

Funding

Eusko Jaurlaritza IT1492-22Eusko Jaurlaritza IT1620-22Ministerio de Ciencia e Innovación PID2022-138266NB-I00
6 · The paper itself

Abstract

Maximizing the binding properties of thermoresponsive molecularly imprinted nanoparticles (MIN) was aimed to explore their feasibility as antibody substitutes in protein immunoprecipitation (IPP) with magnetic streptavidin beads (MSB). Thermoresponsive MIN targeting the cannabinoid CB

Indexed as

ImmunoprecipitationMolecular ImprintingPeptidesStreptavidinGlutathione TransferaseHydrogen-Ion ConcentrationMagnetite NanoparticlesNanoparticlesTemperatureGlutathione TransferaseMagnetite NanoparticlesPeptidesStreptavidinArtificial antibodyCB1 receptorEpitope imprintingImmunoprecipitationMolecularly imprinted nanoparticlesThermoresponsive polymers

Identifiers

PMID39470840
PMCPMC11522088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.